Braveheart
- Website
- braveheart.bio
- Total Funding
- $185.0M
- Last Round
- $185.0M Series ANov 2025
- Rounds
- 1
About
Clinical-stage biotech developing precision therapy for hypertrophic cardiomyopathy and related conditions
Summary
Braveheart is a Healthcare company. It has raised $185.0M in total across 1 round, most recently a $185.0M Series A round in Nov 2025. Investors include Andreessen Horowitz, Forbion Capital Partners and OrbiMed.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2025
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe